Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
2.560
-0.280 (-9.86%)
At close: Nov 4, 2024, 4:00 PM
2.550
-0.010 (-0.39%)
After-hours: Nov 4, 2024, 7:23 PM EST
Fractyl Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 0.12 | 0.12 | - | - | - | - |
Cost of Revenue | 0.07 | 0.08 | - | - | - | - |
Gross Profit | 0.05 | 0.04 | - | - | - | - |
Selling, General & Admin | 20.7 | 12.84 | 15.03 | 10.49 | 6.53 | 9.03 |
Research & Development | 50.73 | 38.04 | 34.35 | 26.44 | 22.43 | 20.89 |
Operating Expenses | 71.43 | 50.88 | 49.39 | 36.93 | 28.96 | 29.92 |
Operating Income | -71.38 | -50.84 | -49.39 | -36.93 | -28.96 | -29.92 |
Interest Expense | - | - | - | -1.46 | -1.53 | -0.8 |
Interest & Investment Income | 3.16 | 1.26 | 0.8 | 0.02 | 0.03 | 0.16 |
Other Non Operating Income (Expenses) | 8.45 | -6.82 | 0.13 | -0.37 | -0.02 | -0.04 |
EBT Excluding Unusual Items | -59.77 | -56.39 | -48.46 | -38.74 | -30.48 | -30.59 |
Other Unusual Items | 4.3 | -20.7 | 2 | - | - | - |
Pretax Income | -55.48 | -77.09 | -46.45 | -38.74 | -30.48 | -30.59 |
Net Income | -55.48 | -77.09 | -46.45 | -38.74 | -30.48 | -30.59 |
Preferred Dividends & Other Adjustments | 10.4 | 17.18 | 17.18 | 14.49 | 10.42 | 7.88 |
Net Income to Common | -65.88 | -94.27 | -63.63 | -53.22 | -40.9 | -38.47 |
Shares Outstanding (Basic) | 20 | 2 | 2 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 20 | 2 | 2 | 2 | 2 | 2 |
Shares Change (YoY) | 894.08% | 4.57% | 7.04% | 0.90% | 3.60% | - |
EPS (Basic) | -3.22 | -45.29 | -31.97 | -28.62 | -22.19 | -21.62 |
EPS (Diluted) | -3.22 | -45.29 | -31.97 | -28.62 | -22.19 | -21.62 |
Free Cash Flow | -53.67 | -43.18 | -46.3 | -33.51 | -31.08 | -27.83 |
Free Cash Flow Per Share | -2.62 | -20.75 | -23.26 | -18.02 | -16.86 | -15.64 |
Gross Margin | 41.18% | 35.83% | - | - | - | - |
Operating Margin | -59984.03% | -42363.33% | - | - | - | - |
Profit Margin | -55357.98% | -78559.17% | - | - | - | - |
Free Cash Flow Margin | -45099.16% | -35985.00% | - | - | - | - |
EBITDA | -71.01 | -50.55 | -48.93 | -36.25 | -28.19 | -29.03 |
D&A For EBITDA | 0.37 | 0.29 | 0.45 | 0.68 | 0.77 | 0.89 |
EBIT | -71.38 | -50.84 | -49.39 | -36.93 | -28.96 | -29.92 |
Source: S&P Capital IQ. Standard template.
Financial Sources.